Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 15.43% is 42% below its 5-year average of 26.46%, near the low end of its 5-year range (5.81%–226.73%).
7.12% below its 12-month average of 16.61%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 13.89%.
NET PROFIT MARGIN
15.43%
NET PROFIT MARGIN AVG TTM
16.61%
NET PROFIT MARGIN AVG 3Y
24.27%
NET PROFIT MARGIN AVG 5Y
26.46%
NET PROFIT MARGIN AVG 10Y
24.99%
NET PROFIT MARGIN AVG 15Y
21.63%
NET PROFIT MARGIN AVG 20Y
19.17%
CURRENT VS TTM AVG
-7.12%
CURRENT VS 3Y AVG
-36.43%
CURRENT VS 5Y AVG
-41.68%
CURRENT VS 10Y AVG
-38.25%
CURRENT VS 15Y AVG
-28.66%
CURRENT VS 20Y AVG
-19.49%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+67.63%
vs the sector median at left
Edwards Lifesciences Corporation
Market Cap
$49.69B
Net Profit Margin
15.43%
TTM Avg
16.61%
3Y Avg
24.27%
5Y Avg
26.46%
Market Cap
$48.80B
Net Profit Margin
19.53%
TTM Avg
19.27%
3Y Avg
18.75%
5Y Avg
17.94%
Market Cap
$50.65B
Net Profit Margin
4.52%
TTM Avg
8.06%
3Y Avg
8.30%
5Y Avg
8.27%
Market Cap
$51.58B
Net Profit Margin
0.67%
TTM Avg
0.69%
3Y Avg
0.48%
5Y Avg
0.29%
Market Cap
$45.64B
Net Profit Margin
4.08%
TTM Avg
-0.87%
3Y Avg
-5.42%
5Y Avg
-7.16%
Market Cap
$44.50B
Net Profit Margin
8.10%
TTM Avg
8.63%
3Y Avg
8.47%
5Y Avg
7.22%
Market Cap
$42.57B
Net Profit Margin
3.58%
TTM Avg
20.93%
3Y Avg
21.85%
5Y Avg
22.39%
Market Cap
$40.96B
Net Profit Margin
25.03%
TTM Avg
23.70%
3Y Avg
22.66%
5Y Avg
22.55%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation (EW) | $49.69B | 15.43% | 16.61% | 24.27% | 26.46% |
| Agilent Technologies, Inc. (A)vs › | $48.80B | 19.53% | 19.27% | 18.75% | 17.94% |
| Becton, Dickinson and Company (BDX)vs › | $50.65B | 4.52% | 8.06% | 8.30% | 8.27% |
| Humana Inc. (HUM)vs › | $47.81B | 0.88% | 0.97% | 1.82% | 2.53% |
| Cardinal Health, Inc. (CAH)vs › | $51.58B | 0.67% | 0.69% | 0.48% | 0.29% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.64B | 4.08% | -0.87% | -5.42% | -7.16% |
| IQVIA Holdings Inc. (IQV)vs › | $44.50B | 8.10% | 8.63% | 8.47% | 7.22% |
| Waters Corporation (WAT)vs › | $42.57B | 3.58% | 20.93% | 21.85% | 22.39% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.96B | 25.03% | 23.70% | 22.66% | 22.55% |
| Cencora, Inc. (COR)vs › | $59.71B | 0.79% | 0.49% | 0.59% | 0.22% |
Operating Margin
28.1%
Net Profit Margin
15.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 13.89% |
| 2026-03-31 | 23.09% |
| 2025-12-31 | 5.81% |
| 2025-09-30 | 18.74% |
| 2025-06-30 | 21.52% |
| 2025-03-31 | 25.34% |
| 2024-12-31 | 27.83% |
| 2024-09-30 | 226.73% |
| 2024-06-30 | 26.24% |
| 2024-03-31 | 26.46% |
| 2023-12-31 | 29.21% |
| 2023-09-30 | 30.96% |
| 2023-06-30 | 23.71% |
| 2023-03-31 | 23.33% |
| 2022-12-31 | 29.55% |
| 2022-09-30 | 26.04% |
| 2022-06-30 | 29.58% |
| 2022-03-31 | 27.86% |
| 2021-12-31 | 25.22% |
| 2021-09-30 | 25.96% |
| 2021-06-30 | 35.57% |
| 2021-03-31 | 27.80% |
| 2020-12-31 | 25.97% |
| 2020-09-30 | 28.50% |
| 2020-06-30 | -13.18% |
| 2020-03-31 | 27.52% |
| 2019-12-31 | 23.87% |
| 2019-09-30 | 25.11% |
| 2019-06-30 | 22.29% |
| 2019-03-31 | 25.15% |
| 2018-12-31 | 0.72% |
| 2018-09-30 | 24.92% |
| 2018-06-30 | 29.96% |
| 2018-03-31 | 23.09% |
| 2017-12-31 | 4.02% |
| 2017-09-30 | 20.71% |
| 2017-06-30 | 22.11% |
| 2017-03-31 | 26.06% |
| 2016-12-31 | 20.65% |
| 2016-09-30 | 19.12% |
| 2016-06-30 | 16.67% |
| 2016-03-31 | 20.51% |
| 2015-12-31 | 20.97% |
| 2015-09-30 | 19.19% |
| 2015-06-30 | 18.27% |
| 2015-03-31 | 20.90% |
| 2014-12-31 | 17.67% |
| 2014-09-30 | 15.57% |
| 2014-06-30 | 95.11% |
| 2014-03-31 | 11.54% |
| 2013-12-31 | 14.14% |
| 2013-09-30 | 15.50% |
| 2013-06-30 | 18.04% |
| 2013-03-31 | 28.97% |
| 2012-12-31 | 17.85% |
| 2012-09-30 | 15.45% |
| 2012-06-30 | 14.07% |
| 2012-03-31 | 14.18% |
| 2011-12-31 | 14.67% |
| 2011-09-30 | 12.50% |
| 2011-06-30 | 13.47% |
| 2011-03-31 | 15.80% |
| 2010-12-31 | 16.51% |
| 2010-09-30 | 13.76% |
| 2010-06-30 | 15.74% |
| 2010-03-31 | 14.01% |
| 2009-12-31 | 13.73% |
| 2009-09-30 | 22.57% |
| 2009-06-30 | 14.16% |
| 2009-03-31 | 19.30% |
| 2008-12-31 | 12.30% |
| 2008-09-30 | 10.84% |
| 2008-06-30 | 12.12% |
| 2008-03-31 | 6.13% |
| 2007-12-31 | 5.39% |
| 2007-09-30 | 11.13% |
| 2007-06-30 | 12.80% |
| 2007-03-31 | 12.57% |
| 2006-12-31 | 7.79% |
| 2006-09-30 | 11.24% |
| 2006-06-30 | 13.51% |
| 2006-03-31 | 17.90% |
| 2005-12-31 | 15.46% |
| 2005-09-30 | -1.83% |
| 2005-06-30 | 5.38% |
| 2005-03-31 | 12.53% |
| 2004-12-31 | 10.92% |
| 2004-09-30 | 5.52% |
| 2004-06-30 | 10.87% |
| 2004-03-31 | -26.43% |
| 2003-12-31 | 8.43% |
| 2003-09-30 | 11.89% |
| 2003-06-30 | 9.69% |
| 2003-03-31 | 6.82% |
| 2002-12-31 | 10.68% |
| 2002-09-30 | -10.49% |
